Skip to main content
Clinical Trials/NCT07007299
NCT07007299CompletedNot Applicable

Safety and Efficacy of Integrative Korean Medicine Treatment for Elderly After Traffic Accident: Retrospective Chart Review Study

Jaseng Medical Foundation4 sites in 1 country1,788 target enrollmentStarted: July 16, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
1,788
Locations
4
Primary Endpoint
Numeric Rating Scale (NRS)

Study Overview

Brief Summary

The purpose of this study was to analyze the medical records of elderly traffic accident patients hospitalized at 4 branches of Jaseng Korean Medicine Hospital to determine the status of elderly patients and the effectiveness and safety of Korean medicine combination treatment.

Detailed Description

This study was retrospective chart review study and was conducted in 4 branches of Jaseng Korean Medicine Hospital (Gangnam, Bucheon, Daejeon, Haeundae).

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Retrospective

Eligibility Criteria

Ages
65 Years to — (Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients aged 65 years or older at the time of first visit
  • •Patients who visited our hospital due to symptoms caused by a traffic accident and received integrated oriental medicine treatment at least once as an inpatient treatment

Exclusion Criteria

  • •If only consultation was conducted at the hospital or only Western medicine treatment was conducted
  • •If only outpatient treatment was received without hospitalization
  • •If other researcher judges that participation in the study is difficult

Outcomes

Primary Outcomes

Numeric Rating Scale (NRS)

Time Frame: The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.

NRS uses an 11-point scale to evaluate current main pain and radiating pain where no pain is indicated by '0', and the worst pain imaginable by '10'.

Secondary Outcomes

  • euroqol-5 dimension (EQ-5D)(The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.)
  • Neck Disability Index (NDI)(The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.)
  • Oswestry Disability Index (ODI)(The results are measured for each patient at admission (before) and discharge (after) from January 2021 to December 31, 2023.)
  • Adverse Events (AE)(The period of hospitalization is limited to January 2021 to December 2023.)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (4)

Loading locations...

Similar Trials